Boston Scientific, Medtronic Show Off Neuromodulation Devices Trial Data

Medtronic and Boston Scientific announced study results Friday that they said reflected positively on devices they are selling in the fast-growing field of neuromodulation.

Boston Scientific Corp. presented new clinical trial findings Friday for patients using two different modes in a spinal cord stimulation system, while Medtronic announced the results of a long-running trial of its implantable drug pump for patients with muscle spasticity following a stroke. The companies announced the data as an industry conference gathered this week in Las Vegas.